Church & Dwight Hopes Oral Care, Orajel Reverse Personal Care Slump
This article was originally published in The Tan Sheet
Executive Summary
The firm seeks to make personal care a growth engine again, hoping single-dose Orajel can overcome competition and FDA concerns about benzocaine overdosing.
You may also be interested in...
Church & Dwight Claims Marketplace Advantage With Value Pricing
Church & Dwight relies on a recession-resistant portfolio, innovation, increased marketing and expanded distribution to continue growing despite reduced consumer spending. CEO James Craigie cautions competitor P&G against a price war, and promises to “hold our price caps.”
Church & Dwight Claims Marketplace Advantage With Value Pricing
Church & Dwight relies on a recession-resistant portfolio, innovation, increased marketing and expanded distribution to continue growing despite reduced consumer spending. CEO James Craigie cautions competitor P&G against a price war, and promises to “hold our price caps.”
C&D’s Naturals Could Help Retain Orajel Customers After Benzocaine Warning
Church & Dwight’s Baby Orajel Naturals could fill a potential void in the teething relief market created by FDA’s recent warning children under 2 years should not use the painkiller benzocaine.